Blume Capital Management, Inc. Viatris Inc Transaction History
Blume Capital Management, Inc.
- $481 Million
- Q2 2025
A detailed history of Blume Capital Management, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Blume Capital Management, Inc. holds 169 shares of VTRS stock, worth $1,708. This represents 0.0% of its overall portfolio holdings.
Number of Shares
169
Previous 19
789.47%
Holding current value
$1,708
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding VTRS
# of Institutions
1,127Shares Held
986MCall Options Held
7.62MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA145MShares$1.47 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$937 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD78.8MShares$796 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az66.4MShares$671 Million3.26% of portfolio
-
State Street Corp Boston, MA55.3MShares$559 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $12.3B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...